BPO-27 (racemate)

BPO-27 (racemate) Suppliers list
Company Name: MedChemexpress LLC  
Tel: 021-58955995
Email: sales@medchemexpress.cn
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Kaixin Chemical (Hong Kong) Limited  
Tel: 010-88886666-01 13112345678
Email: loyson@qq.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Email: liming@bio-fount.com
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com

BPO-27 (racemate) manufacturers

  • BPO-27 racemate
  • BPO-27 racemate pictures
  • $39.00
  • 2026-07-14
  • CAS:1314873-02-3
  • Purity: 98.19%
  • Supply Ability: 10g
  • BPO-27 racemate
  • BPO-27 racemate pictures
  • $39.00
  • 2026-07-14
  • CAS:1314873-02-3
  • Purity: 98.19%
  • Supply Ability: 10g
BPO-27 (racemate) Basic information
Product Name:BPO-27 (racemate)
Synonyms:BPO-27 (racemate);BPO 27 RACEMATE; BPO27 RACEMATE;BPO-27 racemat;6H-Pyrimido[4',5':3,4]pyrrolo[2,1-c][1,4]benzoxazine-2-carboxylic acid, 6-(5-bromo-2-furanyl)-7,8,9,10-tetrahydro-7,9-dimethyl-8,10-dioxo-11-phenyl-;Inhibitor,Cystic fibrosis transmembrane conductance regulator,inhibit,BPO27 racemate,Autophagy,BPO-27,BPO 27,BPO 27 racemate,BPO27,CFTR;6-(5-bromofuran-2-yl)-7,9-dimethyl-8,10-dioxo-11-phenyl-7,8,9,10-tetrahydro-6H-benzo[b]pyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazine-2-carboxylic acid;BPO-27 racemate, 10 mM in DMSO
CAS:1314873-02-3
MF:C26H18BrN3O6
MW:548.34
EINECS:
Product Categories:
Mol File:1314873-02-3.mol
BPO-27 (racemate) Structure
BPO-27 (racemate) Chemical Properties
Boiling point 732.9±70.0 °C(Predicted)
density 1.68±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 6 mg/mL (10.94 mM)
form Solid
pka3.76±0.40(Predicted)
color White to off-white
Safety Information
MSDS Information
BPO-27 (racemate) Usage And Synthesis
UsesBPO-27 racemate is a potent CFTR inhibitor with an IC50 of 8 nM.
in vivo

Following bolus interperitoneal administration in mice, serum (R)-1 decays with t1/2 ≈ 1.6 h and gives sustained therapeutic concentrations in kidney[1].

References[1] Snyder DS, et al. Absolute Configuration And Biological Properties of Enantiomers of CFTR Inhibitor BPO-27. ACS Med Chem Lett. 2013 May 9;4(5):456-459. DOI:10.1021/ml400069k
[2] Kim Y, et al. Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP. Mol Pharmacol. 2015 Oct;88(4):689-96. DOI:10.1124/mol.115.098368
BPO-27 (racemate) Preparation Products And Raw materials
Tag:BPO-27 (racemate)(1314873-02-3) Related Product Information
(S)-Ethyl 6-(5-bromofuran-2-yl)-7,9-dimethyl-8,10-dioxo-11-phenyl-7,8,9,10-tetrahydro-6H-benzo[b]pyrimido[4',5':3,4]pyrrolo[1,2-d][1,4]oxazine-2-carboxylate (R)-BPO-27 BPO-27 (racemate) 13H-17,20-Methano-8,12-nitrilo-12H-pyrido[3,2-d][1,2,6,13]thiatriazacyclooctadecin-5(6H)-one, 2-[3-(2-dispiro[2.0.2.1]hept-7-ylethoxy)-1H-pyrazol-1-yl]-14,15,16,17,18,19-hexahydro-19,19-dimethyl-, 7,7-dioxide, (17S)- GLPG1837 Glibenclamide